<div id="readability-page-1"><div>Wyrick Susan D Chief Financial Officer of Sana Biotechnology Inc [SANA] filed a Form 4 on December 5, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:<div><table><tbody><tr><th>Date</th><th>Transaction</th><th>Shares</th><th>Price</th><th>Value</th></tr><tr><td>6/3/25-12/3/25</td><td>Exercise</td><td>20,000</td><td>$0.00</td><td>N/A</td></tr><tr><td>6/4/25-12/4/25</td><td>Surrender(1)</td><td>5,132</td><td>$3.38</td><td>$17,344</td></tr></tbody></table></div>Ending Holdings: 178,263 - Direct<ul><li>(1)</li><li>Surrender of shares back to company to pay option exercise cost and/or resulting tax liability.</li></ul>For a free trial, or to learn more about our insider trading analysis and data services, please visit http://www.washingtonservice.com or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data. </div></div>

SANA

Sana Biotechnology Inc's CFO, Susan D. Wyrick, filed a Form 4 with the SEC on December 5, 2025, disclosing changes in ownership. She exercised 20,000 shares and surrendered 5,132 shares to cover option exercise costs and tax liabilities, resulting in 178,263 direct holdings.

CFO Wyrick Acquires 14,868 Of Sana Biotechnology Inc [SANA]